Home > Health > Global Pneumococcal Vaccine Market by Manufacturers, Regions, Type and Application, Forecast to 2021

Global Pneumococcal Vaccine Market by Manufacturers, Regions, Type and Application, Forecast to 2021

Added: (Sat Jan 07 2017)

Pressbox (Press Release) - "Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.

There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines.

23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate vaccines contain PCV 7/13 (Pfizer) and PCV10 (GSK).
"

Scope of the Report:
This report focuses on the Pneumococcal Vaccine in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
MSD
Sanofipasteur
CDIBP
Pfizer
GSK

Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America, Middle East and Africa

Market Segment by Type, covers
PPSV 23
PCV 7/13
PCV 10

Market Segment by Applications, can be divided into
Infants
Children (2-10)
Person (10-64)
The old (≥65)

There are 13 Chapters to deeply display the global Pneumococcal Vaccine market.

Chapter 1, to describe Pneumococcal Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Pneumococcal Vaccine, with sales, revenue, and price of Pneumococcal Vaccine, in 2015 and 2016;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2015 and 2016;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Pneumococcal Vaccine, for each region, from 2011 to 2016;

Chapter 5, 6, 7 and 8, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 9 and 10, to show the market by type and application, with sales market share and growth rate by type, application, from 2011 to 2016;

Chapter 11, Pneumococcal Vaccine market forecast, by regions, type and application, with sales and revenue, from 2016 to 2021;

Chapter 12 and 13, to describe Pneumococcal Vaccine sales channel, distributors, traders, dealers, appendix and data source.

Submitted by:Sanjay Jain
Disclaimer: Pressbox disclaims any inaccuracies in the content contained in these releases. If you would like a release removed please send an email to remove@pressbox.co.uk together with the url of the release.